dsip 5 mg (5mg vials) Order DSIP (5mg) | Buy

Supply unlicensed medicinal products (specials) GOV.UK

In a 56-day phase-2 trial, 9 participants with severe dry eye syndrome were treated with synthetic TB4 eye drops or placebo for 28 days, followed by a 28-day observational period

FOXO4-DRI is studied within the senolytic compound class alongside navitoclax and quercetin analogs, with researchers using it as a peptide-based mechanistic comparator targeting the FOXO4-p53 axis specifically

Recovery & injury repair BPC-157, TB-500, and the GLOW/KLOW blends

Brain Behav (2020) 10:e01677

Soares P, Silva C, Chavarria D et al (2023) Drug discovery and amyotrophic lateral sclerosis: emerging challenges and therapeutic opportunities